Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Birkenmeier, Gerd ^a   Stegemann, Christin ^a   Hoffmann, Ralf ^a   Günther, Robert ^a   Huse, Klaus ^b   Birkemeyer, Claudia ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; LACTOYLGLUTATHIONE LYASE; DISULFIDE; GLUTATHIONE; METHIONINE;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL PROCEDURES; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYME REGULATION; ERYTHROCYTE; GLUTATHIONYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; OXIDATION; OXIDATION REDUCTION REACTION; DRUG ANTAGONISM; ENZYMOLOGY; MASS SPECTROMETRY; METABOLISM; PROTEIN PROCESSING;

ACETYLATION; DISULFIDES; ERYTHROCYTES; GLUTATHIONE; HUMANS; LACTOYLGLUTATHIONE LYASE; MASS SPECTROMETRY; METHIONINE; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77956446949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010399     Document Type: Article

References (58)

1. Thornalley PJ (1993) The Glyoxalase System in Health and Disease. Mol Aspects Med 14(4): 287-371.
2. Thornalley PJ (1998) Glutathione-dependent detoxification of alpha-oxoalde-hydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Interact 111-112: 137-151.
3. Ratliff DM, Van der Jagt DJ, Eaton RP, Van der Jagt DL (1996) Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II-a clinical research center study. J Clin Endocrinol Metab 81(2): 488-492.
4. Kuhla B, Boeck K, Schmidt A, Ogunlade V, Arendt T, et al. (2007) Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging 28(1): 29-41.
5. Ayoub F, Zaman M, Thornalley P, Masters J (1993) Glyoxalase activities in human tumour cell lines in vitro. Anticancer Res 13(1): 151-155.
6. Staniszewska MM, Nagaraj RH (2006) Upregulation of glyoxalase I fails to normalize methylglyoxal levels: a possible mechanism for biochemical changes in diabetic mouse lenses. Mol Cell Biochem 288(1-2): 29-36.
7. Chauhan SC, Madhubala R (2009) Glyoxalase I gene deletion mutants of Leishmania donovani exhibit reduced methylglyoxal detoxification. PLOS One 4(8): e6805.
8. Cooper AJ, Kristal BS (1997) Multiple roles of glutathione in the central nervous system. Biol Chem 378(8): 793-802.
9. Cameron AD, Olin B, Ridderstrom M, Mannervik B, Jones TA (1997) Crystal structure of human glyoxalase I - evidence for gene duplication and 3D domain swapping. Embo J 16(12): 3386-3395.
10. Ridderstrom M, Mannervik B (1996) Optimized heterologous expression of the human zinc enzyme glyoxalase I. Biochem J 314(Pt 2): 463-467.
11. Thornalley PJ (2003) Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 31(Pt 6): 1343-1348.
12. de Hemptinne V, Rondas D, Vandekerckhove J, Vancompernolle K (2007) Tumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I. Biochem J 407(1): 121-128.
13. Van Herreweghe F, Mao J, Chaplen FW, Grooten J, Gevaert K, et al. (2002) Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE. Proc Natl Acad Sci USA 99(2): 949-954.
14. Hemptinne F, Rondas D, Toepoel M, Vancompernolle K (2009) Phosphory-lation on Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional activity of NF-kB. Mol Cell Biochem 325: 169-178.
15. Mitsumoto A, Kim KR, Oshima G, Kunimoto M, Okawa K, et al. (2000) Nitric Oxide Inactivates Glyoxalase I in Cooperation with Glutathione. J Biochem 128(4): 647-654.
16. Mitsumoto A, Kim KR, Oshima G, Kunimoto M, Okawa K, et al. (1999) Glyoxalase I is a novel nitric-oxide-responsive protein. Biochem J 344(Pt 3): 837-844.
17. Clugston SL, Barnard JF, Kinach R, Miedema D, Ruman R, et al. (1998) Overproduction and characterization of a dimeric non-zinc glyoxalase I from Escherichia coli: evidence for optimal activation by nickel ions. Biochemistry 37(24): 8754-8763.
18. Stokvis E, Clugston SL, Honek JF, Heck AJ (2000) Characterization of Glyoxalase I (E. coli)-Inhibitor Interactions by Electrospray Time-of-Flight Mass Spectrometry and Enzyme Kinetic Analysis. J Protein Chem 19(5): 389-397.
19. Ranganathan S, Walsh ES, Godwin AK, Tew KD (1993) Cloning and Characterization of Human Colon Glyoxalase 1, J Biol Chem 268(8): 5661-5667.
20. Perkins DN, Pappin DJ, Creasy DM, Cottrell, S J (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18): 3551-3567.
21. Polevoda B, Sherman F (2000) N-a-terminal Acetylation of Eukaryotic Proteins. J Biol Chem 275(47): 36479-36482.
22. Yen TY, Joshi RK, Yan H, Seto NO, Palcic MM, et al. (2000) Characterization of cysteine residues and disulfide bonds in proteins by liquid chromatography/ electrospray ionization tandem mass spectrometry. J Mass Spectrom 35(8): 990-1002.
23. Yen TY, Yan H, Macher BA (2002) Characterizing closely spaced, complex disulfide bond patterns in peptides and proteins by liquid chromatography/ electrospray ionization tandem mass spectrometry. J Mass Spectrom 37(1): 15-30.
24. Cameron AD, Ridderström M, Olin B, Kavarana MJ, Creighton DJ, et al. (1999) Reaction Mechanism of Glyoxalase I Explored by an X-ray Crystallo-graphic Analysis of the Human Enzyme in Complex with a Transition State Analogue. Biochemistry 38(41): 13480-13490.
25. Whittaker VP (1947) An Experimental Investigation of the 'Ring Hypothesis' of Arsenical Toxicity. Biochem J 41(1): 56-62.
26. Shelton M, Mieyal J (2008) Regulation by Reversible S-Glutathionylation: Molecular Targets Implicated in Inflammatory Diseases. Mol Cells 25(3): 332-346.
27. Ghezzi P, Bonetto V (2003) Redox proteomics: Identification of oxidatively modified proteins. Proteomics 3(7): 1145-1153.
28. Gallogly MM, Mieyal JJ (2007) Mechanisms of reversible protein glutathionyla-tion in redox signaling and oxidative stress. Curr Opin Pharmacol 7(4): 381-391.
29. Grimm LM, Collison MW, Fisher RA, Thomas JA (1985) Protein mixed-disulfides in cardiac cells. S-litiolation of soluble proteins in response to diamide. Biochim Biophys Acta 844(1): 50-54.
30. Mohr S, Hallak H, de Boitte A, Lapetina EG, Brune B (1999) Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274(14): 9427-9430.
31. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS (2007) Oxidative stress inhibits human p53 by glutathionylation of cysteines in the proximal DNA-binding domain and disruption of dimerization. Biochemistry 46(26): 7765-7780.
32. Qanungo S, Starke DW, Pai HV, Mieyal JJ, Nieminen AL (2007) Glutathione Supplementation Potentiates Hypoxic Apoptosis by S-Glutathionylation of p65-NFkB. J Biol Chem 282(25): 18427-18436.
33. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, et al. (2002) Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci USA 99: 3505-3510.
34. Michelet L, Zaffagnini M, Massot V, Keryer E, Vanacker H, et al. (2006) Thioredoxins, glutaredoxins, and glutathionylation: new crosstalks to explore. Photosynth Res 89(2-3): 225-245.
35. Fratelli M, Demol H, Puype M, Casagrande S, Villa P, et al. (2003) Identification of proteins undergoing glutathionylation in oxidatively stressed hepatocytes and hepatoma cells. Proteomics 3(7): 1154-1161.
36. Melchers J, Dirdjaja N, Ruppert T, Krauth-Siegel RL (2007) Glutathionylation of Trypanosomal Thiol Redox Proteins. J Biol Chem 282(12): 8678-8694.
37. Cliffe EE, Waley SG (1961) The Mechanism of the Glyoxalase I Reaction, and the Effect of Ophthalmic Acid as an Inhibitor. Biochem J 79: 475-482.
38. Vander Jagt DL, Hassebrook RK, Hunsaker LA, Brown WM, Royer RE (2001) Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications. Chem-Biol Interactions. pp 130-132, 549-562.
39. Hollenbach M, Hintersdorf A, Huse K, Sack U, Bigl M, et al. (2008) Ethyl pyruvate and ethyl lactate down-regulate the production of pro-inflammatory cytokines and modulate expression of immune receptors. Biochem Pharmacol 76: 631-644.
40. Klatt P, Lamas S (2002) C-Jun regulation by S-glutathionylation. Methods Enzymol 348: 157-174.
41. Lan Y (1995) Evidence for a (triosephophate Isomerase-like) ''Catalytic Loop'' near the active Site of Glyoxalase I. J Biol Chem 270(22): 12957-12960.
42. Sellin S, Eriksson LEG, Mannervik B (1982) Fluorescence and Nuclear Relaxation Enhancement Studies of the Binding of Glutathione Derivatives to Manganese-Reconstituted Glyoxalase I from Human Erythrocytes. A Model for the Catalytic Mechanism of the Enzyme Involving a Hydrated Metal Ion. Biochemistry 21: 4850-4875.
43. Hurd TR, Filipovska A, Costa NJ, Dahm CC, Murphy MP (2005) Disulphide formation on mitochondrial protein thiols. Biochem Soc Trans 33(Pt 6): 1390-1393.
44. Chiarugi P, Fiaschi T, Taddei ML, Talini D, Giannoni E, et al. (2001) Two Vicinal Cysteines Confer a Peculiar Redox Regulation to Low Molecular Weight Protein Tyrosine Phosphatase in Response to Platelet-derived Growth Factor Receptor Stimulation. J Biol Chem 276(36): 33478-33487.
45. Carugo O, Cemazar M, Zahariev S, Hudáky I, Gáspári Z, et al. (2003) Vicinal disulfide turns. Protein Eng 16(9): 637-639.
46. Wouters MA, George RA, Haworth NL (2007) ''Forbidden'' Disulfides: Their Role as Redox Switches. Curr Protein Pept Sci 8(5): 484-495.
47. Guy GR, Cairns J, Ng SB, Tan YH (1993) Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J Biol Chem 268(3): 2141-2148.
48. Laden BP, Porter TD (2001) Inhibition of human squalene monooxygenase by tellurium compounds: evidence of interaction with vicinal sulfhydryls. J Lipid Res 42(2): 235-240.
49. Ralph SJ (2008) Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action. Met Based Drugs 2008(260146): 1-13.
50. Verspohl E (2006) Effect of PAO (phenylarsine oxide) on the Inhibitory Effect of Insulin and IGF-1 on Insulin Release from INS-1 Cells. Endocr J 53(1): 21-26.
51. Gilge JL, Fisher M, Chai Y-C (2008) The Effect of Oxidant and the Non-Oxidant Alteration of Cellular Thiol Concentration on the Formation of Protein Mixed-Disulfides in HEK 293 Cells. PLoS One 3(12): e4015.
52. Atkins TW, Thornally PJ (1989) Erythrocyte glyoxalase activity in genetically obese (ob/ob) and streptozotocin diabetic mice. Diabetes Res 11(3): 125-9.
53. Prins HK, Oort M, Loos JA, Zuercher C, Beckers T (1966) Congenital nonspherocytic hemolytic anemia, associated with glutathione deficiency of the erythrocytes. Blood 27(2): 145-66.
54. Santel T, Pflug G, Hemdan NYA, Schaefer A, Hollenbach M, et al. (2008) Cucurmin Inhibits Glyoxalase 1- A Possible Link to its Anti-Inflammatory and Anti-Tumor Activity. PLoS ONE 3(10): e3508.
55. de Arriba SG, Stuchbury G, Yarin J, Burnell J, Loske C, et al. (2007) Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells - protection by carbonyl scavengers. Neurobiol Aging 28(7): 1044-1050.
56. Lee H, Howell SK, Sanford RJ, Beisswenger P (2005) Methylglyoxal can modify GAPDH activity and structure. Ann N Y Acad Sci 1043: 135-145.
57. Laga M, Cottyn A, Van Herreweghe F, Vanden Berghe W, Haegeman G, et al. (2007) Methylglyoxal suppresses TNF-a-induced NF-kB activation by inhibiting NF-kB DNA-binding. Biochem Pharmacol 74(4): 579-589.
58. Mannervik B, Aronsson AC, Tibbelin G (1982) Carbohydrate Metabolism. Methods Enzymol 90(Pt E): 535-541.